A 59-year-old man with type 2 diabetes, hypertension, microalbuminuria, and prior myocardial infarction is on Metformin, Ramipril, and Atorvastatin. H...

Question

A 59-year-old man with type 2 diabetes, hypertension, microalbuminuria, and prior myocardial infarction is on Metformin, Ramipril, and Atorvastatin. HbA1c is 8.1%. According to Diabetes Canada pharmacologic guidelines, which additional agent is most appropriate to prioritise?

Accepted Answer

SGLT2 inhibitor with proven cardiovascular benefit

Answer

Gliclazide

Answer

Basal insulin

Answer

DPP-4 inhibitor

Answer

Thiazolidinedione

ca-mccqe1 MCQ (SBA): Type 2 diabetes pharmacologic management

A 59-year-old man with type 2 diabetes, hypertension, microalbuminuria, and prior myocardial infarction is on Metformin, Ramipril, and Atorvastatin. HbA1c is 8.1%. According to Diabetes Canada pharmacologic guidelines, which additional agent is most appropriate to prioritise?